Moore SM - Search Results

1

Rabies vaccine response measurement is assay dependent.

Moore SM, Pralle S, Engelman L, Hartschuh H, Smith M. Moore SM, et al. Biologicals. 2016 Nov;44(6):481-486. doi: 10.1016/j.biologicals.2016.09.007. Epub 2016 Oct 7. Biologicals. 2016. PMID: 27726931

2

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.

Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF. Tims T, et al. Among authors: moore sm. Vaccine. 2000 Jun 15;18(25):2804-7. doi: 10.1016/s0264-410x(00)00088-8. Vaccine. 2000. PMID: 10812222

3

Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.

Lees CY, Briggs DJ, Wu X, Davis RD, Moore SM, Gordon C, Xiang Z, Ertl HC, Tang DC, Fu ZF. Lees CY, et al. Among authors: moore sm. Vet Microbiol. 2002 Apr 2;85(4):295-303. doi: 10.1016/s0378-1135(01)00523-5. Vet Microbiol. 2002. PMID: 11856579

4

Vaccination of Egyptian fruit bats (Rousettus aegyptiacus) with monovalent inactivated rabies vaccine.

Peters C, Isaza R, Heard DJ, Davis RD, Moore SM, Briggs DJ. Peters C, et al. Among authors: moore sm. J Zoo Wildl Med. 2004 Mar;35(1):55-9. doi: 10.1638/03-027. J Zoo Wildl Med. 2004. PMID: 15193074

5

The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.

Moore SM, Ricke TA, Davis RD, Briggs DJ. Moore SM, et al. Biologicals. 2005 Dec;33(4):269-76. doi: 10.1016/j.biologicals.2005.06.005. Epub 2005 Sep 15. Biologicals. 2005. PMID: 16168666

6

Detection of cellular immunity to rabies antigens in human vaccinees.

Moore SM, Wilkerson MJ, Davis RD, Wyatt CR, Briggs DJ. Moore SM, et al. J Clin Immunol. 2006 Nov;26(6):533-45. doi: 10.1007/s10875-006-9044-0. Epub 2006 Sep 9. J Clin Immunol. 2006. PMID: 16964551

7

Rabies-specific antibodies: measuring surrogates of protection against a fatal disease.

Moore SM, Hanlon CA. Moore SM, et al. PLoS Negl Trop Dis. 2010 Mar 9;4(3):e595. doi: 10.1371/journal.pntd.0000595. PLoS Negl Trop Dis. 2010. PMID: 20231877 Free PMC article. Review.

8

Risk factors for inadequate antibody response to primary rabies vaccination in dogs under one year of age.

Wallace RM, Pees A, Blanton JB, Moore SM. Wallace RM, et al. Among authors: moore sm. PLoS Negl Trop Dis. 2017 Jul 31;11(7):e0005761. doi: 10.1371/journal.pntd.0005761. eCollection 2017 Jul. PLoS Negl Trop Dis. 2017. PMID: 28759602 Free PMC article.

9

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.

Gogtay NJ, Munshi R, Ashwath Narayana DH, Mahendra BJ, Kshirsagar V, Gunale B, Moore S, Cheslock P, Thaker S, Deshpande S, Karande S, Kumbhar D, Ravish HS, Harish BR, Pisal SS, Dhere R, Parulekar V, Blackwelder WC, Molrine DC, Kulkarni PS. Gogtay NJ, et al. Clin Infect Dis. 2018 Jan 18;66(3):387-395. doi: 10.1093/cid/cix791. Clin Infect Dis. 2018. PMID: 29020321 Clinical Trial.

10

Rabies: Current Preventive Strategies.

Moore SM. Moore SM. Vet Clin North Am Small Anim Pract. 2019 Jul;49(4):629-641. doi: 10.1016/j.cvsm.2019.02.014. Epub 2019 Apr 5. Vet Clin North Am Small Anim Pract. 2019. PMID: 30961994 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

366 results

Search Page